Lower thyroid stimulating hormone levels elevate risk of thyroid cancer

September 14, 2017 by Rosalind D'eugenio
Lower thyroid stimulating hormone levels elevate risk of thyroid cancer
A doctor performing physical exam palpation of the thyroid gland. Credit: Dreamstime

There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.

The Yale-led study, published in American Association for Cancer Research journal examined the effect of Thyroid Stimulating Hormone (TSH) on the development of human papillary thyroid (PTC).

Study findings were based on 741 participants (341 women, 400 men) from the U.S. military who had regular blood draws stored by the Armed Forces Surveillance Center. When tested, an inverse association between PTC and TSH levels within the normal range was observed among both men and women. PTC decreased with increased TSH levels among both men and women, the researchers found.

"Earlier studies showed that higher TSH level increases the risk of PTC. However, these were case-control studies in which TSH levels were measured in collected among patients who had already had the disease," said Yawei Zhang, M.D., Ph.D., an associate professor at the Yale School of Public Health. "Our study looked at TSH levels measured in blood samples collected several years before the disease diagnosis, therefore, our study demonstrated that low TSH level increases PTC. These findings could have significant clinical implications for physicians managing patients with abnormal thyroid functions."

Thyroid cancer has the highest prevalence of all endocrine malignancies, and its incidence is increasing faster than any other malignancy among both men and women. In the United States, thyroid cancer is the ninth most common cancer and PTC accounts for more than 80 percent of all thyroid cancers. But causal factors underlying remain poorly understood. TSH is the major growth factor of thyroid cells and regulator of functions.

Explore further: Thyroid cancer tied to regular thyroxine use in hypothyroidism

Related Stories

Thyroid cancer tied to regular thyroxine use in hypothyroidism

July 31, 2017
(HealthDay)—Patients with primary hypothyroidism who are regular thyroxine users have increased risk of thyroid cancer, according to a study published online July 19 in the Journal of Clinical Pharmacology.

Poor thyroid function may affect dialysis patients' quality of life and daily living

July 13, 2017
A new study indicates that impaired thyroid function may have detrimental effects on dialysis patients' health and well-being. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology ...

Review links obesity to increased thyroid cancer risk

September 24, 2015
(HealthDay)—Obesity is associated with increased risk of thyroid cancer, according to a review published online Sept. 14 in Obesity Reviews.

Exposure to common flame retardants may raise the risk of papillary thyroid cancer

April 2, 2017
Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday at the Endocrine Society's ...

Thyroid cancer: treatment and prognosis

March 21, 2017
Dear Mayo Clinic: How is thyroid cancer treated? Does it always require taking out the thyroid? When is iodine treatment used, and how does that work?

ATA guidelines available as pocket cards, mobile apps

March 11, 2017
(HealthDay)—Two additional quick-reference tools, which offer guidance on management of various thyroid disorders, have been launched by the American Thyroid Association.

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.